Organogenesis Holdings (ORGO) EBT Margin (2017 - 2026)

Organogenesis Holdings' EBT Margin history runs 10 years deep, the most recent figure standing at 183.93% for Q1 2026.

• In Q1 2026, EBT Margin fell 15419.0% year-over-year to 183.93%; the TTM figure through Mar 2026 stood at 0.83% (up 612.0% YoY), while the FY2025 annual figure was 8.33%, up 891.0% from the prior year.
• EBT Margin was 183.93% for Q1 2026 at Organogenesis Holdings, down from 28.11% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 28.11% in Q4 2025 to a low of 183.93% in Q1 2026.
• Historically, EBT Margin has averaged 9.38% across 5 years, with a median of 1.04% in 2022.
• The sharpest annual moves came in 2025 and 2026: EBT Margin surged 2002 bps in 2025, then slumped 15419 bps in 2026.
• A 5-year view of EBT Margin shows it stood at 7.58% in 2022, then slumped by 124 bps to 1.8% in 2023, then surged by 549 bps to 8.1% in 2024, then soared by 247 bps to 28.11% in 2025, then sank by 754 bps to 183.93% in 2026.
• The last three EBT Margin figures came in at 183.93% (Q1 2026), 28.11% (Q4 2025), and 14.03% (Q3 2025), per Business Quant data.